Clinical Trial Update: Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a microbiotic product intended to promote microbiome health and potentially enhance chemotherapy delivery in metastatic c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Microbiotic product to promote microbiome health

Snippet

Sponsor: Howard S. Hochster, MD | Conditions: Metastatic Colon Carcinoma, Stage IV Colon Cancer AJCC v8 | Phase 2 | Status: RECRUITING